Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia

A Singanayagam, J D Chalmers, Ahsan Akram, A T Hill

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to investigate whether inhaled corticosteroid (ICS) use affects outcome in patients with chronic obstructive pulmonary disease (COPD) admitted with community-acquired pneumonia (CAP). This was a prospective, observational study of patients with spirometry-confirmed COPD presenting with a primary diagnosis of CAP in Lothian, UK. Outcome measures were compared between ICS users and non-ICS users. Of 490 patients included in the study, 76.7% were classified as ICS users. ICS users had higher Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage compared with non-ICS users (mean ± sd 3.2 ± 0.8 versus 2.6 ± 0.9; p
Original languageEnglish
Pages (from-to)36-41
Number of pages6
JournalEuropean Respiratory Journal
Volume38
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint Dive into the research topics of 'Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia'. Together they form a unique fingerprint.

Cite this